Forecasting Folly:CLSA Edition

Hat Tip: Aniruddha Jain

Around 5 months back,CLSA came out with a “Sell” recommendation on Biocon which led to a very public Twitter fight between the Biocon CEO and an analyst.


Biocon was trading around Rs.534 when CLSA issued the Sell Recommendation.

Its trading around Rs.723 today,up by almost 35% in the space of 5 months.

Forecasting Folly,anyone?

4 replies on “Forecasting Folly:CLSA Edition”

Normally love your forecasting follies – but this is too short a time frame to judge.

PS: I have no views on Biocon and completely neutral.

I believed in their syn-gen listing and bought at 438 per share 50 share and sitting in profit . Commonsense needed it is no rocket science

It is up, could because of trading and 35% is not high enough to confirm anything. In my opinion biocon is yet to prove. Two years down the line there is possibility that this post could come in forecast folly 🙂

Leave a Reply

Your email address will not be published. Required fields are marked *